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Abstract 
 
The purpose of this study was to evaluate the Etest as an in vitro antifungal 
susceptibility test method for different moulds originating from human samples and from the 
environment. A total of 50 isolates (1 Acremonium, 18 Aspergillus, 2 Cladosporium, 
1 Epicoccum, 15 Penicillium, 2 Scopulariopsis and 11 Trichoderma strains) were tested by 
the Etest. 46 of the tested moulds (92%) were resistant to fluconazole with minimal inhibitory 
concentrations (MICs) ≥ 256 µg ml−1. There were strains resistant to itraconazole among 
Aspergillus niger, Aspergillus ochraceus and Cladosporium spp. with MICs > 32 µg ml−1. For 
fluconazole, no differences were observed using two different inocula, while for itraconazole, 
ketoconazole and amphotericin B, a 1 or less step 2-fold dilution difference in MIC was seen 
for the most of 10 selected strains. The MICs of fluconazole and amphotericin B obtained for 
Trichoderma strains by the Etest and the agar dilution method were also compared. MICs for 
fluconazole were in agreement, while MICs for amphotericin B were higher with 1 or 2 steps 
of 2-fold dilutions for most of Trichoderma strains in the case of the agar dilution method. 
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Introduction 
 
The incidence of fungal infections has been increasing since the 1980s. The increasing 
number of susceptible hosts (organ or bone marrow transplant patients) as well as the use of 
immunsuppressive agents and antimicrobial prophylactic strategies has probably contributed 
to the changing epidemiology of mycoses [1]. The volume of disseminated infections caused 
by filamentous fungi (moulds) is lower than that caused by yeasts [2]. Most infections caused 
by moulds originate from the environment by inhalation through the respiratory tract or 
contamination (e.g. postoperative wounds, heart valves, etc.) [3]. The most frequently isolated 
moulds are Aspergillus spp.: A. fumigatus is responsible for a large majority (85-90%) of the 
different clinical manifestations of several mould infections [2]. However, the importance of 
other moulds (Penicillium, Cladosporium and Scopulariopsis spp.) has also been increasing. 
Moulds are able to cause infections of the respiratory tract (e.g. pneumonia, allergic 
bronchopulmonary mycosis, aspergilloma, allergic fungal rhinosinusitis, etc.) and superficial, 
cutaneous, osseous or invasive mould infections [4–10]. 
 The in vitro susceptibility testing of filamentous fungi is becoming increasingly 
important because of the frequency and diversity of the infections they cause [11]. The 
standard method for determination of the MICs of filamentous fungi (the NCCLS broth 
microdilution method [12, 13]) and the Etest were compared in previous studies [2, 14, 15]. In 
the case of many moulds, good correlations have been demonstrated for amphotericin B and 
itraconazole, but the results depended on the species tested and the nutrient media used for 
susceptibility testing [2, 14]. 
This report summarizes the antifungal susceptibility results on filamentous fungi 
isolated from clinical specimens and from the environment, obtained by the Etest method.   
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Materials and methods 
 
Isolates 
 
A total number of 50 isolates were tested, including 44 clinical isolates obtained from 
different specimens (from the upper or lower respiratory tract, the gastrointestinal tract, the 
genital tract or the peritoneal fluid as well as mucocutaneous samples). Strains were isolated 
from Sabouraud chloramphenicol agar (Sanofi Diagnostics Pasteur, Marnes-La-Coquette, 
France) and maintained on Sabouraud chloramphenicol agar slants until use in this study. The 
clinical isolates included 7 Trichoderma strains obtained from the American Type Culture 
Collection (Manassas, USA) and the University of Alberta Microfungus Collection and 
Herbarium, these strains originated from immunosuppressed patients with various infections. 
Among 6 strains originating from the environment, 4 Trichoderma isolates were studied 
earlier for cold tolerance [16].  
 All isolates were subcultured on Sabouraud chloramphenicol agar plates and incubated 
at 30 °C until adequate growth was attained before their use in susceptibility testing. 
 
Etest for MIC determinations  
 
The Etest was performed according to the manufacturer’s instructions (AB Biodisk; 
Solna, Sweden) [17]. Spore suspensions were adjusted to match the 0.5 McFarland standard. 
The medium used was RPMI 1640 agar (15 g l−1) supplemented with 20 g l−1 glucose. This 
medium was dispensed in 20 ml amounts into Petri dishes (90 mm in diameter) giving an agar 
depth of 4 ± 0.5 mm. These plates were inoculated by dipping a sterile swab into the inoculum 
suspension and streaking it across the entire surface in three directions. The plates were dried 
at room temperature for 15 min before the application of the Etest strips. (The drug 
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concentrations ranged from 0.016 to 256 mg l−1 for fluconazole, and from 0.002 to 32 mg l−1 
for itraconazole, ketoconazole and amphotericin B). The plates were incubated at 30 °C and 
read after incubation for 24, 48 or 72 hours according to the growth conditions of the isolates. 
The MIC was read as the drug concentration at which the elliptical inhibition zone intersected 
the scale on the antifungal test strip.  
 
 Agar dilution method 
 
The susceptibility of Trichoderma strains was evaluated for fluconazole and 
amphotericin B by the agar dilution method as well [18]. Stock solutions of 2 mg ml−1 were 
prepared from amphotericin B (Bristol-Myers Squibb AG, Baar) and fluconazole (Pfizer, 
Amboise, France) in sterile distilled water. 20 ml aliquots of RPMI 1640 agar (15 g l−1) 
supplemented with 20 g l−1 glucose were used to fill the 90-mm-diameter Petri dishes. 
Appropriate quantities of the stock solutions were added to the molten and cooled medium to 
reach final concentrations of 4–512 µg ml−1 for fluconazole and 0.25–32 µg ml−1 for 
amphotericin B, corresponding to the Etest concentrations. The medium was mixed and 
allowed to solidify undisturbed. Control plates containing the test medium without 
antimicrobial agents were prepared for each strain.  
3-mm-diameter discs were cut from the edges of young colonies of Trichoderma 
strains [16]. One disc was inoculated onto each plate, and the plates were then incubated at 
30 °C for 48 hours. The MIC was read as the lowest drug concentration at which no growth of 
the microorganisms was detected. 
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Results 
 
During the past years (2000-2002), 50 filamentous fungi originating from different 
specimens were evaluated. Table I shows the origin and distribution of the isolates. No 
parallel isolates from the same patient were involved in the study.  
32 human isolates were cultured from specimens from the upper or lower respiratory 
tract: mucin from the nose, washing fluid from the paranasal sinuses or nose, specimens from 
the ears or thoracic fluid. 3 isolates were from the peritoneal fluid, 4 from the gastrointestinal 
tract, 3 from mucocutaneous samples and 2 from the genital tract. The most frequently 
isolated species were A. versicolor among the Aspergillus spp. and P. chrysogenum among 
the Penicillium spp. The 6 isolates from environmental samples were Epicoccum nigrum (1), 
Scopulariopsis spp. (1), T. citrinoviride (1), T. koningii (1), T. longibrachiatum (1) and T. 
pseudokoningii (1). 
These fungi were tested and evaluated for their susceptibilities to fluconazole, 
ketoconazole, itraconazole and amphotericin B by the Etest (Table II). 46 of the tested moulds 
(92%) were resistant to fluconazole, with MIC >256 µg ml−1. The range of MICs for 
ketoconazole was wide: there were resistant strains with MICs >32 µg ml−1 among the A. 
niger, A. ochraceus and Cladosporium spp., while the lowest MIC values were obtained for 
the Trichoderma strains (0.008−0.5 µg ml−1). Two strains were resistant to amphotericin B 
with MIC values >32 µg ml−1.  
For 10 selected isolates, the MICs obtained by the Etest were measured by using two 
different spore suspension turbidities. The MICs obtained after incubation for 48 or 72 hours 
are listed in Table III. For fluconazole, no differences were observed with the two inocula: all 
strains were fully resistant. For itraconazole, ketoconazole and amphotericin B, a 1- or 2-step 
2-fold dilution difference in MIC was seen for most strains with the exception of A. niger 2. 
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and A. ochraceus: significant differences in MICs were detected for ketoconazole and 
itraconazole in the case of these two strains.  
The MICs of fluconazole and amphotericin B obtained for 10 Trichoderma strains by 
the Etest and the agar dilution method were compared. Table IV presents these results 
together with data from appropriate references. The MICs of fluconazole obtained for 8 
strains with the two methods were in agreement, but higher values were obtained by the Etest 
for strain T. koningii T 39. Higher MICs were obtained for amphotericin B with the agar 
dilution method than with the Etest in the case of 7 strains.  
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Discussion 
 
Most of the infections caused by moulds originate from the environment. These fungi 
pass into the human body through breathing, food or contamination. During the past two 
years, moulds were isolated most frequently from the upper respiratory tract. Predominantly 
these areas (nose, paranasal sinuses and ears) are exposed to fungal spores. Isolates from the 
gastrointestinal tract originated from contaminated food: most of these fungi are evacuated 
from the organism, but they may be the origin of serious mould infections in 
immunosuppressed patients [20]. The rates of Aspergillus spp. (18 isolates) and Penicillium 
spp. (15 isolates) in human specimens during the 2-year period were similar. Acremonium 
spp., Cladosporium spp. and Scopulariopsis spp. were isolated in small numbers. 
 There have been previous reports on comparisons of antifungal susceptibility testing 
methods for moulds [2, 14, 15], and a good correlation was observed between the Etest and 
broth microdilution methods. In this present study, most strains were resistant to fluconazole 
by the Etest (Table II), while ketoconazole, itraconazole and amphotericin B were more 
effective. For most strains, the MICs were not influenced significantly by the turbidity of 
spore suspension (Table III). For 8 of 10 strains, there were no or only small differences 
between the MICs obtained on the use of 3 McFarland and 0.5 McFarland suspensions (in 
accordance with the manufacturer’s instruction). If the higher inoculum was used for some 
slow-growing isolates, the MICs could be read 1 day earlier. Higher differences were detected 
for 2 Aspergillus strains: A. niger and A. ochraceus. The MICs of these strains for 
amphotericin B and fluconazole did not differ markedly, and were similar to the itraconazole 
MIC of A. ochraceus. These moulds grew rapidly and covered the surface of the agar plates 
completely (with the exception of the inhibition zone) when a higher turbidity of suspension 
was used. The cultures were thicker, which influenced the MICs. More exact values could be 
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obtained if the turbidity of the spore suspension was measured spectrophotometrically in the 
case of black moulds. 
The differences in MIC values obtained by comparison of the Etest and the agar 
dilution methods were similar for the evaluated Trichoderma strains (Table IV). The MICs for 
fluconazole did not differ markedly with these methods, but they did differ by 1 or 2 steps of 
2-fold dilutions from the data in the literature obtained by broth dilution methods. The MICs 
for amphotericin B were higher by 1 or 2 steps of 2-fold dilutions with the agar dilution 
method.  
 In conclusion, these data indicated differences between the susceptibility testing 
methods for moulds. The agar dilution method was not the most appropriate for the 
susceptibility testing of moulds in routine laboratory use, because the exact results depended 
on numerous features (e.g. the stability of the solution of antimycotics, the mixing of the stock 
solutions into the agar medium, the growth rate of the moulds, etc.). The Etest is easier to 
perform: it is less labour-intensive and much simpler to set up than the broth microdilution or 
agar dilution methods [2, 15] and it provides the flexibility to test antifungal agents against 
different moulds [14].  
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Table I  
Origin of moulds evaluated for antifungal susceptibility 
No. of isolates 
Species Gastrointestinal 
tract 
 Upper and 
lower 
respiratory tract 
Peritoneal 
fluid 
Mucocutaneous 
samples 
Genital 
tract 
Environmental 
samples 
Total No. of isolates 
(% of all) 
Acremonium spp. 0 1 0 0 0 0 1 (2%) 
A. candidus 0 1 0 0 0 0 1 (2%) 
A. fumigatus 0 4 0 0 0 0 4 (8%) 
A. niger 0 4 0 1 0 0   5 (10%) 
A. ochraceus 0 2 0 0 0 0 2 (4%) 
A. versicolor  0 3 0 1 2 0   6 (12%) 
Cladosporium spp. 0 2 0 0 0 0 2 (4%) 
E. nigrum 0 0 0 0 0 1 1 (2%) 
P. chrysogenum 0 6 0 0 0 0   6 (12%) 
P. humicola 2 0 0 0 0 0 2 (4%) 
P. humuli 0 4 0 0 0 0 4 (8%) 
Penicillium spp. 0 3 0 0 0 0 3 (6%) 
Scopulariopsis spp. 1 0 0 0 0 1 2 (4%) 
T. citrinoviride 0 0 1 0 0 1 2 (4%) 
T. koningii 0 0 1 0 0 1 2 (4%) 
T. longibrachiatum 1 2 1 1 0 1   6 (12%) 
T. pseudokoningii 0 0 0 0 0 1 1 (2%) 
Total 4 32 3 3 2 6 50 (100%) 
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Table II 
Antifungal susceptibilities of moulds evaluated by the Etest method   
(Range of) MICs (µg ml−1) Species (No. of tested 
isolates) 
Incubation 
time (h) Fluconazole Ketoconazole Itraconazole Amphotericin B 
Acremonium spp. (1) 72 >256 0.5 >32 2 
A. candidus (1) 72 >256 0.032 0.004 8 
A. fumigatus (4) 48 >256 0.125 – 4 0.25 – 1 0.016 – 2 
A. niger (5) 24, 48 8 - >256 0.016 – >32 0.032 – 4 0.25 – 1 
A. ochraceus (2) 48 >256 2 and >32 1 and 4 8 and >32 
A. versicolor (6) 48, 72 >256 0.064 – 0.5 0.125 – 2 0.032 – 16 
Cladosporium spp. (2) 48, 72 >256 0.064 and >32 0.5 and 1 0.032 and 2 
E. nigrum (1) 72 >256 0.016 0.016 0.125 
P. chrysogenum (6) 48, 72 >256 0.25 – 1 0.125 - >32 4 – >32 
P. humicola (2) 48 >256 0.25 and 0.5 8 and >32 8 
P. humuli (4) 48, 72 64 and >256 0.25 – 1 0.064 – 2 0.125 – 1 
Penicillium spp. (3) 48, 72 >256 0.125 – 0.5 1 – 2 0.25 – 8 
Scopulariopsis spp. (2) 48 >256 0.125 and 1 1 and >32 0.5 and 1 
T  T. citrinoviride (2) 48 >256 0.25 and 0.5 24 0.064 and 2 
T  T. koningii (2) 48 >256 0.25 2 and 4 0.5 and 8 
T  T. longibrachitaum (6) 48 8 - >256 0.008 – 0.5 1 – 32 1 – 2 
T  T. pseudokoningii (1) 48 >256 0.25 8 0.25 
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Table III 
Influence of turbidity of spore suspension on MICs 
MICs (µg ml−1) 
Species McFarland Incubation time (h) Fluconazole Ketoconazole Itraconazole Amphotericin B 
A. fumigatus 1. 0.5 48 >256 2 1 0.25 
 3 48 >256 4 1 0.5 
A. fumigatus 2. 0.5 48 >256 4 0.25 0.016 
 3 48 >256 4 0.25 0.016 
A. niger 1. 0.5 48 >256 2 2 0.25 
 3 48 >256 2 2 0.25 
A. niger 2. 0.5 48 >256 0.5 4 0.25 
 3 48 >256 >32 32 0.5 
A. ochraceus 0.5 48 >256 2 1 >32 
 3 48 >256 >32 2 >32 
A. versicolor 0.5 72 >256 0.125 1 0.25 
 3 72 >256 0.25 1 0.5 
P. humuli 0.5 72 >256 0.5 2 1 
 3 48 >256 0.5 2 1 
Penicillium spp. 0.5 72 >256 0.5 2 8 
 3 48 >256 0.5 2 8 
Scopulariopsis spp. 0.5 48 >256 1 1 0.5 
 3 48 >256 2 1 0.5 
S. brevicaulis  0.5 72 >256 0.125 >32 1 
 3 48 >256 0.25 >32 1 
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Table IV  
MIC values obtained by Etest and agar dilution method for Trichoderma spp. 
 
MIC values (µg ml−1) 
Fluconazole Amphotericin B Species Identity 
Etest Agar dilution  Etest Agar dilution 
T. citrinoviride UAMH 9573 64 64 2 2 
T. koningii T 39 >256 64 0.5 2 
T. koningii CM 382 a >256 512 8 16 
T. longibrachiatum TK 51 >256 256 2 4 
T. longibrachiatum UAMH 7955 >256 256 1 4 
T. longibrachiatum UAMH 7956 b 64 64 2 8 
T. longibrachiatum UAMH 9515 >256 512 2 4 
T. longibrachiatum ATCC 201044 c 64 32 2 2 
T. longibrachiatum ATCC 208859 >256 256 2 4 
T. pseudokoningii T 29 >256 256 0.25 0.25 
 
a
 Ref. 19: MICs : fluconazole: 128 µg ml−1; amphotericin B: 4 µg ml−1 (by broth microdilution method) 
b
 Ref. 20: MICs: fluconazole: 16 µg ml−1; amphotericin B: 2 µg ml−1 (by broth microdilution method) 
c
 Ref. 21: MICs: fluconazole: ?64 µg ml−1; amphotericin B: 2 µg ml−1 (by broth macrodilution method) 
 
